ATAGI Advice - Vaccination after testing positive for COVID-19

ATAGI continues to advise that previous infection is not a contraindication to vaccination and vaccination can occur following recovery of acute illness from COVID-19.

People who have had COVID-19 can be vaccinated with a COVID-19 vaccine once they recover from the acute illness. There is no requirement to delay vaccination, however vaccination can be deferred for up to 4 months as past infection reduces the chance of reinfection for at least this amount of time.


  • If a patient tests positive for COVID-19 between their first and second doses, or between their second and booster dose, the patient should delay next dose until they have recovered from the acute illness.
  • People with prolonged symptoms from COVID-19 beyond 4 months should be vaccinated on a case by case basis.
  • Temporary exemption from COVID-19 vaccination: Those with a PCR-confirmed SARS-CoV-2 infection can temporarily defer vaccination up until 4 months after the infection. The time frame for temporary exemptions was previously 6 months. ATAGI has decreased the time allowable for deferral of vaccination after prior SARS-CoV-2 infection to 4 months due to the increased risk of re-infection with the Omicron variant, particularly for those who had a Delta variant infection in 2021.
  • More information is available in ATAGI's Expanded Guidance on temporary medical exemptions for COVID-19 vaccines and ATAGI update following weekly COVID-19 meeting –19 January 2022
  • You can also seek further advice from a specialist immunisation service if required.

Related topics